FERMENTAPharmaceuticals
Fermenta Biotech Ltd — Balance Sheet
₹319.05
-4.70%
Fermenta Biotech Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Treasury Shares Number | 0.03 Cr | 0.06 Cr | 0.06 Cr | 0.06 Cr | — |
| Ordinary Shares Number | 2.92 Cr | 2.89 Cr | 2.89 Cr | 2.88 Cr | — |
| Share Issued | 2.94 Cr | 2.94 Cr | 2.94 Cr | 2.94 Cr | — |
| Net Debt | 81.16 Cr | 110.44 Cr | 181.55 Cr | 223.09 Cr | — |
| Total Debt | 114.94 Cr | 138.77 Cr | 219.52 Cr | 239.18 Cr | — |
| Tangible Book Value | 355.56 Cr | 277.59 Cr | 290.51 Cr | 343.58 Cr | — |
| Invested Capital | 472.07 Cr | 421.13 Cr | 532.16 Cr | 608.28 Cr | — |
| Working Capital | 123.36 Cr | 68.49 Cr | 44.30 Cr | 106.90 Cr | — |
| Net Tangible Assets | 355.56 Cr | 277.59 Cr | 290.51 Cr | 343.58 Cr | — |
| Capital Lease Obligations | 5.54 Cr | 6.50 Cr | 2.68 Cr | 3.04 Cr | — |
| Common Stock Equity | 362.67 Cr | 288.86 Cr | 315.31 Cr | 372.13 Cr | — |
| Total Capitalization | 377.72 Cr | 331.40 Cr | 398.90 Cr | 486.82 Cr | — |
| Total Equity Gross Minority Interest | 358.52 Cr | 285.16 Cr | 312.56 Cr | 371.45 Cr | — |
| Minority Interest | -4.16 Cr | -3.70 Cr | -2.75 Cr | -0.68 Cr | — |
| Stockholders Equity | 362.67 Cr | 288.86 Cr | 315.31 Cr | 372.13 Cr | — |
| Other Equity Interest | 0.30 Cr | 12.73 Cr | 13.25 Cr | 14.69 Cr | — |
| Retained Earnings | 325.38 Cr | 252.93 Cr | 279.43 Cr | 326.38 Cr | — |
| Additional Paid In Capital | 17.82 Cr | 3.07 Cr | 2.23 Cr | 0.70 Cr | — |
| Capital Stock | 14.58 Cr | 14.44 Cr | 14.43 Cr | 14.42 Cr | — |
| Common Stock | 14.58 Cr | 14.44 Cr | 14.43 Cr | 14.42 Cr | — |
| Total Liabilities Net Minority Interest | 255.96 Cr | 262.67 Cr | 323.95 Cr | 335.39 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 44.08 Cr | 89.41 Cr | 115.23 Cr | 128.27 Cr | — |
| Other Non Current Liabilities | 14.05 Cr | 13.97 Cr | 15.00 Cr | 5.00 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 7.81 Cr | 5.35 Cr | 4.62 Cr | 5.65 Cr | — |
| Non Current Deferred Revenue | 0.16 Cr | 18.47 Cr | 8.94 Cr | 0.24 Cr | — |
| Long Term Debt And Capital Lease Obligation | 19.49 Cr | 48.07 Cr | 85.58 Cr | 116.65 Cr | — |
| Long Term Capital Lease Obligation | 4.44 Cr | 5.54 Cr | 1.99 Cr | 1.97 Cr | — |
| Long Term Debt | 15.05 Cr | 42.54 Cr | 83.59 Cr | 114.68 Cr | — |
| Long Term Provisions | 7.81 Cr | 5.35 Cr | 4.62 Cr | 5.65 Cr | — |
| Current Liabilities | 211.88 Cr | 173.26 Cr | 208.72 Cr | 207.12 Cr | — |
| Other Current Liabilities | 0.97 Cr | 1.19 Cr | 0.18 Cr | 0.21 Cr | — |
| Current Deferred Taxes Liabilities | 4.41 Cr | 0.34 Cr | 0.33 Cr | 0.32 Cr | — |
| Current Debt And Capital Lease Obligation | 95.44 Cr | 90.69 Cr | 133.94 Cr | 122.53 Cr | — |
| Current Capital Lease Obligation | 1.09 Cr | 0.96 Cr | 0.69 Cr | 1.07 Cr | — |
| Current Debt | 94.35 Cr | 89.73 Cr | 133.26 Cr | 121.46 Cr | — |
| Current Provisions | 0.90 Cr | 1.06 Cr | 2.61 Cr | 1.03 Cr | — |
| Payables | 81.94 Cr | 72.67 Cr | 49.37 Cr | 70.84 Cr | — |
| Other Payable | 4.27 Cr | 7.59 Cr | 3.42 Cr | 6.12 Cr | — |
| Dividends Payable | 0.19 Cr | 0.17 Cr | 0.15 Cr | 0.14 Cr | — |
| Total Tax Payable | 4.41 Cr | 0.34 Cr | 0.33 Cr | 0.32 Cr | — |
| Accounts Payable | 77.49 Cr | 64.90 Cr | 45.79 Cr | 64.58 Cr | — |
| Total Assets | 614.48 Cr | 547.83 Cr | 636.52 Cr | 706.84 Cr | — |
| Total Non Current Assets | 279.24 Cr | 306.08 Cr | 383.49 Cr | 392.82 Cr | — |
| Other Non Current Assets | 0.54 Cr | 1.05 Cr | 1000.00 | 0.90 Cr | — |
| Non Current Prepaid Assets | 3.57 Cr | 3.42 Cr | 7.63 Cr | 0.59 Cr | — |
| Non Current Deferred Assets | 0.08 Cr | 0.11 Cr | 0.00 | 0.02 Cr | — |
| Non Current Deferred Taxes Assets | 28.64 Cr | 22.00 Cr | 33.26 Cr | 35.99 Cr | — |
| Investmentin Financial Assets | 2.00 Cr | 1.13 Cr | 1.84 Cr | 4.51 Cr | — |
| Available For Sale Securities | 2.00 Cr | 1.13 Cr | 1.84 Cr | 4.51 Cr | — |
| Long Term Equity Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investmentsin Associatesat Cost | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investment Properties | 3.19 Cr | 5.41 Cr | 28.71 Cr | 67.28 Cr | — |
| Goodwill And Other Intangible Assets | 7.11 Cr | 11.27 Cr | 24.80 Cr | 28.55 Cr | — |
| Other Intangible Assets | 3.00 Cr | 7.16 Cr | 13.27 Cr | 17.60 Cr | — |
| Goodwill | 4.12 Cr | 4.12 Cr | 11.53 Cr | 10.95 Cr | — |
| Net PPE | 232.32 Cr | 253.71 Cr | 259.51 Cr | 240.69 Cr | — |
| Accumulated Depreciation | -117.68 Cr | -101.54 Cr | -82.00 Cr | -66.63 Cr | — |
| Gross PPE | 350.00 Cr | 355.24 Cr | 341.52 Cr | 307.33 Cr | — |
| Construction In Progress | 16.07 Cr | 1.85 Cr | 42.95 Cr | 33.26 Cr | — |
| Other Properties | 216.25 Cr | 251.86 Cr | 216.56 Cr | 207.43 Cr | — |
| Machinery Furniture Equipment | 213.96 Cr | 210.07 Cr | 189.22 Cr | 181.61 Cr | — |
| Buildings And Improvements | 117.47 Cr | 132.42 Cr | 98.44 Cr | 81.56 Cr | — |
| Land And Improvements | 2.50 Cr | 10.90 Cr | 10.90 Cr | 10.90 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 335.23 Cr | 241.75 Cr | 253.02 Cr | 314.02 Cr | — |
| Other Current Assets | 0.03 Cr | 16.02 Cr | 0.45 Cr | 34000.00 | — |
| Current Deferred Assets | 0.18 Cr | 0.28 Cr | 0.46 Cr | 0.45 Cr | — |
| Restricted Cash | 1.23 Cr | 0.17 Cr | 1.19 Cr | 7.92 Cr | — |
| Prepaid Assets | 19.98 Cr | 20.06 Cr | 14.48 Cr | 25.36 Cr | — |
| Inventory | 123.65 Cr | 87.38 Cr | 130.14 Cr | 159.48 Cr | — |
| Finished Goods | 37.36 Cr | 14.18 Cr | 39.09 Cr | 33.49 Cr | — |
| Work In Process | 40.35 Cr | 33.59 Cr | 34.17 Cr | 60.65 Cr | — |
| Raw Materials | 45.95 Cr | 39.62 Cr | 56.88 Cr | 65.33 Cr | — |
| Other Receivables | 24.27 Cr | 4.20 Cr | 4.60 Cr | 7.92 Cr | — |
| Accounts Receivable | 95.23 Cr | 69.83 Cr | 41.65 Cr | 87.20 Cr | — |
| Allowance For Doubtful Accounts Receivable | -4.07 Cr | -4.51 Cr | -4.30 Cr | -4.21 Cr | — |
| Gross Accounts Receivable | 99.29 Cr | 74.33 Cr | 45.95 Cr | 91.42 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 70.66 Cr | 59.82 Cr | 60.06 Cr | 25.69 Cr | — |
| Other Short Term Investments | 42.42 Cr | 38.00 Cr | 24.77 Cr | 12.64 Cr | — |
| Cash And Cash Equivalents | 28.24 Cr | 21.83 Cr | 35.29 Cr | 13.06 Cr | — |
| Cash Financial | 28.24 Cr | 21.83 Cr | 35.17 Cr | 11.92 Cr | — |
| Cash Equivalents | — | 0.00 | 0.13 Cr | 1.13 Cr | 3.29 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Fermenta Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.